PRSS35 Antikörper (AA 30-340)
Kurzübersicht für PRSS35 Antikörper (AA 30-340) (ABIN7873580)
Target
Alle PRSS35 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 30-340
-
Verwendungszweck
- PRSS35 Antibody / Inactive serine protease 35
-
Aufreinigung
- Antigen affinity purified
-
Immunogen
- E. coli-derived recombinant human protein (amino acids H30-D340) was used as the immunogen for the PRSS35 antibody.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal dilution of the PRSS35 antibody should be determined by the researcher.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Buffer
- 0.5 mg/mL if reconstituted with 0.2 mL sterile DI water
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- After reconstitution, the PRSS35 antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.
-
-
- PRSS35 (Protease, serine, 35 (PRSS35))
-
Andere Bezeichnung
- PRSS35
-
Hintergrund
- Proteolytic degradation of extracellular matrix components has been suggested to play an essential role for the occurrence of ovulation. The plasminogen activator and matrix metalloproteinase systems, which were previously believed to be crucial for ovulation, are not required in this process. PRSS35, which was upregulated by gonadotropins. PRSS23 was highly expressed in atretic follicles and it was expressed in the ovarian stroma and theca tissues just prior to ovulation. PRSS35 was expressed in the theca layers of developing follicles. It was also highly induced in granulosa cells of preovulatory follicles. PRSS35 was also expressed in the forming and regressing CL. PRSS35 may be involved in ovulation and CL formation and regression, and that PRSS23 may play a role in follicular atresia.
-
UniProt
- Q8N3Z0
Target
-